Physician's knowledge and experience with the off-label use of medicines
The off-label use of medicines is neither prohibited nor explicitly allowed, according to the current European Union (EU) pharmaceutical legislation. This can cause confusion in physicians’ practice as well as lead to patients’ dissatisfaction. The purpose of this survey is to assess the knowledge a...
Main Authors: | Maria Drenska, Emilia Naseva, Ilko Getov |
---|---|
Format: | Article |
Language: | English |
Published: |
Taylor & Francis Group
2021-01-01
|
Series: | Biotechnology & Biotechnological Equipment |
Subjects: | |
Online Access: | http://dx.doi.org/10.1080/13102818.2020.1856718 |
Similar Items
-
Research on Approaches for Regulation of the “Off-label” use of Medicinal Products in the European Union
by: Drenska M., et al.
Published: (2017-05-01) -
The knowledge and experience with the off-label use – results of a survey
by: Maria Drenska, et al.
Published: (2019-12-01) -
Analysis of primary outpatient data for off-label use of medicines in neurology
by: Maria Drenska, et al.
Published: (2019-12-01) -
Evaluation of Knowledge, Attitudes and Experience of off-label Drug Prescribing Practice among Physicians in Baghdad City Hospitals
by: Aysha M. Shanshal, et al.
Published: (2019-12-01) -
An online survey of Australian physicians reported practice with the off-label use of nebulised frusemide
by: Newton Phillip J, et al.
Published: (2012-04-01)